Shiny White Blotches, Strands Linked to High Diagnostic Specificity in Basal Cell Carcinoma

Share this content:
The presence of shiny white blotches and strands were linked to high diagnostic specificity for nonpigmented basal cell carcinoma.
The presence of shiny white blotches and strands were linked to high diagnostic specificity for nonpigmented basal cell carcinoma.

The presence of shiny white blotches and strands were linked to high diagnostic specificity for nonpigmented basal cell carcinoma (BCC), according to a study published in JAMA Dermatology.1

Shiny white structures (SWSs) are often present in basal cell carcinoma, the most common type of skin cancer, which is often nonpigmented. Investigators sought to determine the diagnostic accuracy of various morphologies of SWSs.

Data were collected from 2375 patients and included 2891 biopsied skin lesions, of which 457 were nonpigmented neoplasms.  SWSs were categorized as blotches, strands, short white lines, and rosettes. The study's primary endpoint was diagnosis of BCC compared with all other diagnoses combined. Secondary outcome was diagnosis of BCC compared with amelanotic melanoma.

Out of the 457 neoplasms, 62.8% were BCCs, 23.2% were squamous cell carcinoma, 8.5% were lichen planus-like keratosis, 4.6% were melanomas, and 0.9% were nevi. SWSs occurred in 49% of neoplasms.

RELATED: FDA Approves Sonidegib for Locally Advanced Basal Cell Carcinoma

SWS presence was linked with a diagnosis of BCC (odds ratio 2.3; 95% CI, 1.5 – 3.6; P <.001). Blotches and strands  were linked with BCC (6.3; 95% CI, 3.6 – 10.9; P < .001 and 4.9; 95% CI, 2.9 – 8.4); P < .001, respectively). The presence of both blotches and strands had an odds ratio of 6.1 (95% CI, 3.3 – 11.3; P < .001). Shiny white blotches and strands had a diagnostic sensitivity of 30% and a specificity of 91%.

Reference

  1. Navarrete-Dechent C, Bajaj S, Marchetti MA, et al. Association of shiny white blotches and strands with nonpigmentented basal cell carcinoma: evaluation of an additional dermoscopic diagnostic criterion [published online ahead of print January 20, 2016]. JAMA Dermatol. doi: 10.1001/jamadermatol.2015.5731.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters